- Home
- VOR vs CTO Comparison
VOR vs CTO Comparison
Compare VOR & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VOR | CTO |
|---|---|---|
| Founded | 2015 | 1902 |
| Country | United States | United States |
| Employees | N/A | 42 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.6M | 643.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | VOR | CTO |
|---|---|---|
| Price | $15.03 | $19.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $64.78 | $21.50 |
| AVG Volume (30 Days) | ★ 664.4K | 255.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.75% |
| EPS Growth | ★ 2.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.63 |
| Revenue Next Year | N/A | $2.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $15.07 |
| 52 Week High | $49.95 | $20.25 |
Technical Indicators
Market Signals| Indicator | VOR | CTO |
|---|---|---|
| Relative Strength Index (RSI) | 54.23 | 64.94 |
| Support Level | $11.27 | $17.29 |
| Resistance Level | $16.95 | $20.25 |
| Average True Range (ATR) | 1.17 | 0.42 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 54.04 | 65.40 |
Price Performance
Historical ComparisonAbout VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a real estate investment trust company, that owns income properties in diversified markets in the United States. The company operates in four primary business segments: Income properties, management services, commercial loans and investments, and real estate operations. It derives maximum revenue from Income Properties.